Data Protection in China: 17 Years after China's WTO Accession
China introduced dual data protection (both undisclosed information and six-year data exclusivity) for pharmaceutical products from its accession to the WTO. From 2017, a new series of policies proposed up to 12 years of data exclusivity for biologics. The drug negotiation mechanism in China should be considered in evaluating the impacts of these policies on enhanced data protection
|Collections||ANU Research Publications|
|Source:||European Intellectual Property Review (E.I.P.R)|
|01_Cheng_Data_Protection_in_China%3A_17_2018.pdf||326.36 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.